ACLS
AXCELIS TECHNOLOGIES INC
Nasdaq · CIK 1113232
Last close147.77
Daily change+11.06 (8.09%)
10 Years gain+963.86%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ACLS · STANDARD
SIC 3559 · Special Industry Machinery, NEC · Fiscal year end 1231
Fundamental
35.7Momentum
3.2Acceleration
1.9Confidence
91.0Annual Revenue17
Quarterly Revenue71
Annual CFO11
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality8.0 / 25
Capital Efficiency3.4 / 20
Balance Sheet15.0 / 15
Shareholder Economics9.3 / 10
Forward Indicators0.0 / 5
Signals
Share count reductionDiluted share count declined 3.7142%.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 2.281 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 9.3563 percentage points.
ROIC declining · MEDIUMROIC declined by 22.4015 percentage points.
Key Metrics
Revenue Growth TTM-14.17%OK
Revenue CAGR 3Y-3.02%OK
Gross Margin42.31%OK
Operating Margin10%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC11.35%OK
Incremental Operating Margin 3Y-28.22%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-3.71%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $839.05M | $376.85M | $119.32M | $118.31M | $107.01M | 44.91% | 14.22% | 12.75% | 18.84% | 31.67M |
| 2025 FY Dec 31, 2024 | $1.02B | $454.65M | $210.79M | $140.82M | $128.64M | 44.67% | 20.71% | 12.64% | 45.99% | 32.7M |
| 2025 FY Dec 31, 2023 | $1.13B | $491.30M | $265.80M | $156.87M | $136.21M | 43.45% | 23.51% | 12.05% | 79.13% | 33.17M |
| 2024 FY Dec 31, 2022 | $920.00M | $401.79M | $212.36M | $215.61M | $204.92M | 43.67% | 23.08% | 22.27% | 79.21% | 33.54M |
| 2023 FY Dec 31, 2021 | $662.43M | $286.45M | $127.33M | $150.19M | $141.47M | 43.24% | 19.22% | 21.36% | 39.95% | 34.27M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $822.29M | sum latest 4 fiscal quarters Revenue | OK | 0001104659-26-091999, 0001104659-25-107689 |
| Revenue Growth TTM | -14.17% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104659-26-091999, 0001104659-25-107689 |
| Revenue CAGR 3Y | -3.02% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-020461 |
| Revenue CAGR 5Y | 12.07% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001104659-26-020461 |
| Gross Profit CAGR 3Y | -2.11% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-020461 |
| Operating Income Growth | -55.66% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001104659-26-091999, 0001104659-25-107689 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 42.31% | Gross Profit / Revenue | OK | 0001104659-26-091999, 0001104659-25-107689 |
| Operating Margin | 10% | Operating Income / Revenue | OK | 0001104659-26-091999, 0001104659-25-107689 |
| ROIC | 11.35% | NOPAT / Average Invested Capital | OK | 0001104659-26-091999, 0001104659-25-107689 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104659-26-091999 |
| Current Ratio | 4.9x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $26.41 | Revenue / Diluted Shares | OK | 0001104659-26-091999, 0001104659-25-107689 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |